DE2539778A1 - N-acetyliertes orgotein - Google Patents

N-acetyliertes orgotein

Info

Publication number
DE2539778A1
DE2539778A1 DE19752539778 DE2539778A DE2539778A1 DE 2539778 A1 DE2539778 A1 DE 2539778A1 DE 19752539778 DE19752539778 DE 19752539778 DE 2539778 A DE2539778 A DE 2539778A DE 2539778 A1 DE2539778 A1 DE 2539778A1
Authority
DE
Germany
Prior art keywords
orgotein
acylorgotein
groups
acyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752539778
Other languages
German (de)
English (en)
Inventor
Wolfgang Huber
Mark G Saifer
Lewis D Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GT Biopharma Inc
Original Assignee
Diagnostic Data Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Data Inc filed Critical Diagnostic Data Inc
Publication of DE2539778A1 publication Critical patent/DE2539778A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE19752539778 1974-09-20 1975-09-06 N-acetyliertes orgotein Withdrawn DE2539778A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/507,685 US4017605A (en) 1974-09-20 1974-09-20 Acylated orgotein

Publications (1)

Publication Number Publication Date
DE2539778A1 true DE2539778A1 (de) 1976-04-08

Family

ID=24019700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752539778 Withdrawn DE2539778A1 (de) 1974-09-20 1975-09-06 N-acetyliertes orgotein

Country Status (21)

Country Link
US (1) US4017605A (enExample)
JP (1) JPS5152101A (enExample)
AT (1) AT346366B (enExample)
BE (1) BE833079A (enExample)
BR (1) BR7506046A (enExample)
CA (1) CA1059504A (enExample)
CH (1) CH621557A5 (enExample)
DD (1) DD122254A5 (enExample)
DE (1) DE2539778A1 (enExample)
DK (1) DK391875A (enExample)
FI (1) FI56186C (enExample)
FR (1) FR2285144A1 (enExample)
GB (1) GB1505879A (enExample)
IE (1) IE42052B1 (enExample)
IL (1) IL47969A (enExample)
IT (1) IT1047070B (enExample)
LU (1) LU73427A1 (enExample)
NL (1) NL7511067A (enExample)
NO (1) NO753209L (enExample)
SE (1) SE7510409L (enExample)
ZA (1) ZA755965B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306622A1 (de) * 1982-03-02 1983-09-15 Italfarmaco S.p.A., 20126 Milano Bio-verfuegbare eisenderivate, die keine gastrischen schaeden verursachen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
EP0292321A3 (en) * 1987-05-21 1990-01-10 Suntory Limited Acylated derivative of superoxide dismutase and composition containing same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070459A (en) * 1975-12-09 1978-01-24 Diagnostic Data, Inc. N-carbamylated orgotein
US4585754A (en) * 1984-01-09 1986-04-29 Valcor Scientific, Ltd. Stabilization of proteins and peptides by chemical binding with chondroitin
US5162217A (en) * 1984-08-27 1992-11-10 Bio-Technology General Corp. Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579495A (en) * 1970-04-24 1971-05-18 Diagnostic Data Inc Isolation of orgotein from blood
US3637640A (en) * 1970-05-04 1972-01-25 Diagnostic Data Inc Orgotein stabilized with saccharide process and products
US3764711A (en) * 1971-03-29 1973-10-09 Carnation Co Acylated protein for coffee whitener formulations
US3758682A (en) * 1972-03-23 1973-09-11 Diagnostics Data Inc Pharmaceutical compositions comprising orgotein and their use

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306622A1 (de) * 1982-03-02 1983-09-15 Italfarmaco S.p.A., 20126 Milano Bio-verfuegbare eisenderivate, die keine gastrischen schaeden verursachen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
AT390067B (de) * 1982-03-02 1990-03-12 Italfarmaco Spa Verfahren zur herstellung von succinylierten proteinen
EP0292321A3 (en) * 1987-05-21 1990-01-10 Suntory Limited Acylated derivative of superoxide dismutase and composition containing same

Also Published As

Publication number Publication date
FR2285144B1 (enExample) 1980-05-30
NL7511067A (nl) 1976-03-23
ZA755965B (en) 1976-09-29
AT346366B (de) 1978-11-10
AU8422875A (en) 1977-03-03
DK391875A (da) 1976-03-21
BR7506046A (pt) 1976-08-03
JPS5152101A (en) 1976-05-08
IE42052L (en) 1976-03-20
FI56186C (fi) 1979-12-10
FR2285144A1 (fr) 1976-04-16
US4017605A (en) 1977-04-12
IE42052B1 (en) 1980-05-21
NO753209L (enExample) 1976-03-23
IT1047070B (it) 1980-09-10
LU73427A1 (enExample) 1977-01-28
FI56186B (fi) 1979-08-31
DD122254A5 (enExample) 1976-09-20
ATA713775A (de) 1978-03-15
IL47969A (en) 1978-06-15
BE833079A (fr) 1976-03-04
CA1059504A (en) 1979-07-31
CH621557A5 (enExample) 1981-02-13
SE7510409L (sv) 1976-03-22
GB1505879A (en) 1978-03-30
IL47969A0 (en) 1975-11-25
FI752581A7 (enExample) 1976-03-21

Similar Documents

Publication Publication Date Title
DE68923723T2 (de) Modifizierter humaner G-CSF.
DE69127020T2 (de) Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel
DE3750906T2 (de) Chemisch modifizierte Proteine und deren Herstellung.
DE69525340T2 (de) Verbesserungen in zusammensetzungen von kopolymeren enthaltend kopolymer-1
DE69030956T2 (de) Inhibierung des Transformierenden Wachstumsfaktors zur Verhinderung der Anhäufung Extrazellulärer Matrix
DE2751717C2 (enExample)
EP0012156A1 (de) Immunserumglobulin (ISG)-Präparate und Verfahren zu ihrer Herstellung
DE2440529C3 (de) Hyaluronidase-Präparat aus menschlicher Plazenta
DE2433883A1 (de) Geschuetztes polypeptid, im wesentlichen nicht immunogene, enzymisch aktive substanz sowie verfahren zum weitgehenden unterdruekken der immunogenizitaet eines polypeptids
Miyahara et al. Age-related differences in human skin collagen: solubility in solvent, susceptibility to pepsin digestion, and the spectrum of the solubilized polymeric collagen molecules
DE69307897T2 (de) Polysaccharide aus glykogen
EP0457370B1 (de) Verfahren zur Pasteurisierung des Gewebeproteins PP4
DE2728925A1 (de) Ovomucoid-fraktion von wachtel-eiweiss, verfahren zu deren herstellung und arzneimittel
DE69132710T2 (de) Verfahren zur Reduzierung von Endotoxin induzierten Effekten
DE2539778A1 (de) N-acetyliertes orgotein
DE2433209A1 (de) Hitzestabile plasmaproteinloesungen, verfahren zu ihrer herstellung und arzneipraeparate
DE2825464A1 (de) Biologisch aktive substanz, verfahren zu deren herstellung und dieselbe enthaltendes pharmazeutisches mittel
DE2713817A1 (de) Verfahren zum gewinnen von immunglobulin
DE68912582T2 (de) Anti-hiv-mittel.
Iwasaki et al. Suppression of neurofilament degradation by protease inhibitors in experimental spinal cord injury
DE69528890T2 (de) Verwendung von substituierten dextranen zur behandlung von schädigungen des nervensystems, und fraktionen mit erhöhtem heparansulfat-gehalt
DE69428020T2 (de) Topische antibakterielle Zusammensetzung
DE69233315T2 (de) Pharmazeutische lysin enthaltende polypeptid-zusammensetzungen und verfahren zu deren verwendung
EP0038667A1 (en) IgM derivatives and process for the preparation thereof
DE2803397C2 (enExample)

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee